These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1047 related articles for article (PubMed ID: 33190346)
1. Pathophysiological mechanisms of liver injury in COVID-19. Nardo AD; Schneeweiss-Gleixner M; Bakail M; Dixon ED; Lax SF; Trauner M Liver Int; 2021 Jan; 41(1):20-32. PubMed ID: 33190346 [TBL] [Abstract][Full Text] [Related]
2. The Impact of COVID-19 on Liver Injury. Dawood DRM; Salum GM; El-Meguid MA Am J Med Sci; 2022 Feb; 363(2):94-103. PubMed ID: 34752738 [TBL] [Abstract][Full Text] [Related]
3. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. Lei HY; Ding YH; Nie K; Dong YM; Xu JH; Yang ML; Liu MQ; Wei L; Nasser MI; Xu LY; Zhu P; Zhao MY Biomed Pharmacother; 2021 Jan; 133():111064. PubMed ID: 33378966 [TBL] [Abstract][Full Text] [Related]
4. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management. Xu Y; Yang X; Bian H; Xia M Lipids Health Dis; 2021 Oct; 20(1):126. PubMed ID: 34602072 [TBL] [Abstract][Full Text] [Related]
5. Hepatic complications of COVID-19 and its treatment. Tian D; Ye Q J Med Virol; 2020 Oct; 92(10):1818-1824. PubMed ID: 32437004 [TBL] [Abstract][Full Text] [Related]
6. The Potential Mechanisms Behind Adverse Effect of Coronavirus Disease-19 on Heart and Liver Damage: A Review. Daba TM; Mokonon M; Niguse E; Getahun M Ethiop J Health Sci; 2024 Jan; 34(1):85-100. PubMed ID: 38957334 [TBL] [Abstract][Full Text] [Related]
7. Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications. Rodriguez-Espada A; Salgado-de la Mora M; Rodriguez-Paniagua BM; Limon-de la Rosa N; Martinez-Gutierrez MI; Pastrana-Brandes S; Navarro-Alvarez N World J Gastroenterol; 2024 Jun; 30(22):2866-2880. PubMed ID: 38947288 [TBL] [Abstract][Full Text] [Related]
8. Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection. Seltzer S Int J Infect Dis; 2020 Dec; 101():42-45. PubMed ID: 32950735 [TBL] [Abstract][Full Text] [Related]
9. Unraveling the Molecular and Cellular Pathogenesis of COVID-19-Associated Liver Injury. Akkiz H Viruses; 2023 May; 15(6):. PubMed ID: 37376587 [TBL] [Abstract][Full Text] [Related]
10. Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination. Nevola R; Criscuolo L; Beccia D; Delle Femine A; Ruocco R; Imbriani S; Alfano M; Villani A; Russo A; Perillo P; Marfella R; Adinolfi LE; Sasso FC; Marrone A; Rinaldi L World J Gastroenterol; 2023 Feb; 29(5):800-814. PubMed ID: 36816617 [TBL] [Abstract][Full Text] [Related]
11. Human and novel coronavirus infections in children: a review. Rajapakse N; Dixit D Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199 [TBL] [Abstract][Full Text] [Related]
13. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship. D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501 [TBL] [Abstract][Full Text] [Related]
14. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19. Kuba K; Yamaguchi T; Penninger JM Front Immunol; 2021; 12():732690. PubMed ID: 35003058 [TBL] [Abstract][Full Text] [Related]
15. COVID-19-associated liver injury: from bedside to bench. Li D; Ding X; Xie M; Tian D; Xia L J Gastroenterol; 2021 Mar; 56(3):218-230. PubMed ID: 33527211 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830 [TBL] [Abstract][Full Text] [Related]
17. COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management. Li P; Liu Y; Cheng Z; Yu X; Li Y Biomed Pharmacother; 2022 Oct; 154():113568. PubMed ID: 36029543 [TBL] [Abstract][Full Text] [Related]